// App-Quantinova.ai

1793 : GSK-3 Spatial Regulation Has an Essential Role in Lenalidomide Activity and Represents a Biomarker of Clinical Response in CLL

Researchers

Presenter

  • Sam Scanga

Principal Investigators

  • Keith Stewart

  • Armen S Manoukian

  • Fabrizio G Mastronardi

  • Ellen Nong Wei

  • Frank Mercurio

  • Antonia Lopez-Girona

  • Svetlana Gaidarova

  • David R. Webb

  • Christine Chen

Medical Centers

  • Richmond Hill, ON, Canada

  • Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada

  • Inceptum Research & Inceptum Research& Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada,

Locations

  • Canada

Companies

  • Celgene Corporation

  • BioTheryX, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Multiple Myeloma

Biomarkers

  • Cluster of Differentiation 19

Drug/Treatment

  • Lenalidomide

  • Thalidomide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved